Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson’s Disease: A Cross-Sectional Study
Marina Peball(Innsbruck Medical University), Klaus Seppi(Innsbruck Medical University), Peter Willeit(Innsbruck Medical University), Heike Stockner(Innsbruck Medical University), Franziska Murr(Innsbruck Medical University), Johann Willeit(Innsbruck Medical University), Stefan Kiechl(Innsbruck Medical University), Roberto De Marzi(Innsbruck Medical University), Florian Krismer(Innsbruck Medical University), Werner Poewe(Innsbruck Medical University), Beatrice Heim(Innsbruck Medical University), Helga Herzmann(Innsbruck Medical University), Gregor K. Wenning(Innsbruck Medical University), Michael Nocker(Innsbruck Medical University), Mario Werkmann(Innsbruck Medical University), Kathrin Marini(Innsbruck Medical University), Katherina Mair(Innsbruck Medical University), Atbin Djamshidian(Innsbruck Medical University), Philipp Mahlknecht(University College London), Dora Valent(Innsbruck Medical University)
Cited by 118
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
|Circulation Research|2010|1.5k